Symbol
| TOR1A
| contributors: npt/mct/pgu - updated : 19-04-2010
|
HGNC name
| torsin family 1, member A (torsin A)
|
HGNC id
| 3098
|
corresponding disease(s)
|
DYT1
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
| germinal mutation
|  
|  
|  
|
GAG mutation, in early-onset recurrent major depression, independently of motor manifestations of dystonia | |
Susceptibility
|
to sporadic idiopathic dystonia |
Variant & Polymorphism
other
| haplotype associated with sporadic idiopathic dystonia |
|
216H allele having highly protective effect in patients with the GAG deletion (increased in carriers without dystonia and decreased in carriers with dystonia) |
|
|
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
neurology | dystonia | | |
specific small molecules that enhance TOR1A activity represent a promising new approach toward therapeutic development for torsion-dystonia, and potentially for other diseases involving the processing of mutant proteins |
| | | |
| ectopic overexpression of both human and C. elegans torsin proteins results in a dramatic reduction of polyglutamine-dependent protein aggregation suggesting a role for torsins in managing protein folding | |
It also suggest that breakdown in a neuroprotective mechanism that is, in part, mediated by torsins may be responsible for the neuronal dysfunction associated with dystonia |